Cargando…

Serum Paraoxonase 1 Activity Status in Patients with Liver Disorders

BACKGROUND/AIM: Paraoxonase 1 (PON1) is an esterase, exclusively synthesized by liver. The present study has two objectives: to determine the PON1 activity status in various disorders associated with hepatocellular damage and to correlate the changes of PON1 activity with the standard liver function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kedage, Vivekananda, Muttigi, Manjunatha S., Shetty, Mahesh S., Suvarna, Renuka, Rao, Soumya S., Joshi, Chitralekha, Prakash, Mungli
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016510/ https://www.ncbi.nlm.nih.gov/pubmed/20339175 http://dx.doi.org/10.4103/1319-3767.61232

Ejemplares similares

Serum paraoxonase activity and protein thiols in chronic renal failure patients
por: Prakash, M., et al.
Publicado: (2008)

Serum Paraoxonase as an Indicator for Fatty Liver in Sheep
por: Cao, Yu, et al.
Publicado: (2017)

Determination of oxidative stress markers and their importance in early diagnosis of uremia-related complications
por: Kolagal, V., et al.
Publicado: (2009)

Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells
por: Selvaraj, Nagarathinam, et al.
Publicado: (2015)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Serum Paraoxonase/Arylesterase Activity and Oxidative Stress Status in Children with Metabolic Syndrome
por: Eren, Erdal, et al.
Publicado: (2014)

Paraoxonases at the Heart of Neurological Disorders
por: Khalaf, Fatimah K., et al.
Publicado: (2023)

Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows
por: Farid, Ayman Samir, et al.
Publicado: (2013)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis
por: Agilli, Mehmet, et al.
Publicado: (2014)

Paraoxonase Activity and Oxidative Status in Patients with Tinnitus
por: Koç, Sema, et al.
Publicado: (2016)

Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1
por: Blaha-Nelson, David, et al.
Publicado: (2016)

The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
por: Moshtaghie, Elham, et al.
Publicado: (2022)

Serum paraoxonase 1 (PON1) measurement: an update
por: Ceron, Jose J, et al.
Publicado: (2014)

Response to: Serum Paraoxonase and Malondialdehyde Levels in Asymptomatic Cholelithiasis
por: Atamer, Aytaç, et al.
Publicado: (2016)

Paraoxonase/MCS.
por: Rowat, S C
Publicado: (1999)

Introduction to Paraoxonases
por: Aviram, Michael
Publicado: (2012)

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients
por: Erdem, Fazile Hatipoglu, et al.
Publicado: (2010)

Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia
por: Kota, Sunil K., et al.
Publicado: (2013)

Serum paraoxonase 1 activity in patients with iron deficiency anemia
por: Okuturlar, Yildiz, et al.
Publicado: (2016)

Paraoxonase 1 activities and polymorphisms in autism spectrum disorders
por: Paşca, Sergiu P, et al.
Publicado: (2010)

Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013)

Theoretical Studies on Catalysis Mechanisms of Serum Paraoxonase 1 and Phosphotriesterase Diisopropyl Fluorophosphatase Suggest the Alteration of Substrate Preference from Paraoxonase to DFP
por: Zhang, Hao, et al.
Publicado: (2018)

The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and -3
por: Taler-Verčič, Ajda, et al.
Publicado: (2020)

Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease
por: Milaciu, Mircea Vasile, et al.
Publicado: (2019)

Harnessing MerTK agonism for targeted therapeutics
por: Kedage, Vivekananda, et al.
Publicado: (2019)

Paraoxonase: Its antiatherogenic role in chronic renal failure
por: Prakash, M., et al.
Publicado: (2010)

Suppression of inflammatory arthritis in human serum paraoxonase 1 transgenic mice
por: Charles-Schoeman, Christina, et al.
Publicado: (2020)

Factors associated to serum paraoxonase 1 activity in patients with cardiovascular disease
por: Longo, Aline, et al.
Publicado: (2021)

Human paraoxonase 2
por: Porntadavity, Sureerut, et al.
Publicado: (2010)

Effects of citral on serum antioxidant status and liver genes expressions of paraoxonase 1 and nitric oxide synthase in a rat model of streptozotocin-induced diabetes mellitus
por: Khosravi Bakhtiari, M., et al.
Publicado: (2021)

Paraoxonase 1 and atherosclerosis
por: Durrington, Paul N., et al.
Publicado: (2023)

Serum Cholinesterase Inhibition in Relation to Paraoxonase-1 (PON1) Status among Organophosphate-Exposed Agricultural Pesticide Handlers
por: Hofmann, Jonathan N., et al.
Publicado: (2009)

Caffeine Increases Apolipoprotein A-1 and Paraoxonase-1 but not Paraoxonase-3 Protein Levels in Human-Derived Liver (HepG2) Cells
por: Sayılan Özgün, Gülben, et al.
Publicado: (2017)

Total Oxidant Status, Total Antioxidant Status, and Paraoxonase and Arylesterase Activities during Laparoscopic Cholecystectomy
por: Koksal, Hande, et al.
Publicado: (2010)

Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
por: Elkiran, Emin T, et al.
Publicado: (2007)

High Prevalence of Low Serum Paraoxonase-1 in Subjects with Coronary Artery Disease
por: Jayakumari, Narayani, et al.
Publicado: (2009)

Long term stability of paraoxonase-1 and high-density lipoprotein in human serum
por: Beekhof, Piet K, et al.
Publicado: (2012)

Paired Measurements of Paraoxonase 1 and Serum Amyloid A as Useful Disease Markers
por: Kotani, Kazuhiko, et al.
Publicado: (2013)

Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients
por: Arenas, Meritxell, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o46a98s7mp129gls3ehg1ocfga